263 related articles for article (PubMed ID: 34113355)
21. HBsAg/β2GPI activates the NF‑κB pathway via the TLR4/MyD88/IκBα axis in hepatocellular carcinoma.
Jing X; Tian Z; Gao P; Xiao H; Qi X; Yu Y; Ding X; Yang L; Zong L
Oncol Rep; 2018 Aug; 40(2):1035-1045. PubMed ID: 29916535
[TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor 2-independent and MyD88-dependent gene expression in the mouse brain.
Naert G; Laflamme N; Rivest S
J Innate Immun; 2009; 1(5):480-93. PubMed ID: 20375605
[TBL] [Abstract][Full Text] [Related]
23. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection.
Hösel M; Quasdorff M; Wiegmann K; Webb D; Zedler U; Broxtermann M; Tedjokusumo R; Esser K; Arzberger S; Kirschning CJ; Langenkamp A; Falk C; Büning H; Rose-John S; Protzer U
Hepatology; 2009 Dec; 50(6):1773-82. PubMed ID: 19937696
[TBL] [Abstract][Full Text] [Related]
24. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.
Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z
J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970
[TBL] [Abstract][Full Text] [Related]
25. Activation of Toll-like receptors by Burkholderia pseudomallei.
West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
[TBL] [Abstract][Full Text] [Related]
26. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice.
Wu J; Lu M; Meng Z; Trippler M; Broering R; Szczeponek A; Krux F; Dittmer U; Roggendorf M; Gerken G; Schlaak JF
Hepatology; 2007 Dec; 46(6):1769-78. PubMed ID: 17929296
[TBL] [Abstract][Full Text] [Related]
27. Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia.
Downer EJ; Johnston DG; Lynch MA
Mol Cell Neurosci; 2013 Sep; 56():148-58. PubMed ID: 23659921
[TBL] [Abstract][Full Text] [Related]
28. A toll-like receptor 2 pathway regulates the Ppargc1a/b metabolic co-activators in mice with Staphylococcal aureus sepsis.
Sweeney TE; Suliman HB; Hollingsworth JW; Welty-Wolf KE; Piantadosi CA
PLoS One; 2011; 6(9):e25249. PubMed ID: 21966468
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of hepatitis B virus replication by MyD88 is mediated by nuclear factor-kappaB activation.
Lin S; Wu M; Xu Y; Xiong W; Yi Z; Zhang X; Zhenghong Y
Biochim Biophys Acta; 2007 Oct; 1772(10):1150-7. PubMed ID: 17935950
[TBL] [Abstract][Full Text] [Related]
30. [Toll-like receptor dependent innate immune responses by primary mouse hepatocytes and its control of HBV replication].
Wu J; Chen MF; Xia YC; Guo Y; Lin Y; Sun C; Zhang CY; Chen Y; Liu SP; Hao YH; Lu MJ; Schlaak JF; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):838-42. PubMed ID: 22433306
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen.
Jegaskanda S; Ahn SH; Skinner N; Thompson AJ; Ngyuen T; Holmes J; De Rose R; Navis M; Winnall WR; Kramski M; Bernardi G; Bayliss J; Colledge D; Sozzi V; Visvanathan K; Locarnini SA; Kent SJ; Revill PA
J Virol; 2014 Sep; 88(18):10412-20. PubMed ID: 24872585
[TBL] [Abstract][Full Text] [Related]
32. Tribbles 3: a novel regulator of TLR2-mediated signaling in response to Helicobacter pylori lipopolysaccharide.
Smith SM; Moran AP; Duggan SP; Ahmed SE; Mohamed AS; Windle HJ; O'Neill LA; Kelleher DP
J Immunol; 2011 Feb; 186(4):2462-71. PubMed ID: 21220698
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C Virus NS3 Mediated Microglial Inflammation via TLR2/TLR6 MyD88/NF-κB Pathway and Toll Like Receptor Ligand Treatment Furnished Immune Tolerance.
Rajalakshmy AR; Malathi J; Madhavan HN
PLoS One; 2015; 10(5):e0125419. PubMed ID: 25965265
[TBL] [Abstract][Full Text] [Related]
34. Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathways.
Pei RJ; Chen XW; Lu MJ
World J Gastroenterol; 2014 Sep; 20(33):11618-29. PubMed ID: 25206268
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus particles activate B cells through the TLR2-MyD88-mTOR axis.
Li Q; Wang J; Islam H; Kirschning C; Lu H; Hoffmann D; Dittmer U; Lu M
Cell Death Dis; 2021 Jan; 12(1):34. PubMed ID: 33414473
[TBL] [Abstract][Full Text] [Related]
36. Pellino-1 Positively Regulates Toll-like Receptor (TLR) 2 and TLR4 Signaling and Is Suppressed upon Induction of Endotoxin Tolerance.
Murphy M; Xiong Y; Pattabiraman G; Qiu F; Medvedev AE
J Biol Chem; 2015 Jul; 290(31):19218-32. PubMed ID: 26082489
[TBL] [Abstract][Full Text] [Related]
37. An alternative model for type I interferon induction downstream of human TLR2.
Oosenbrug T; van de Graaff MJ; Haks MC; van Kasteren S; Ressing ME
J Biol Chem; 2020 Oct; 295(42):14325-14342. PubMed ID: 32796029
[TBL] [Abstract][Full Text] [Related]
38. Gene expression analysis of primary normal human hepatocytes infected with human hepatitis B virus.
Ryu HM; Park SG; Yea SS; Jang WH; Yang YI; Jung G
World J Gastroenterol; 2006 Aug; 12(31):4986-95. PubMed ID: 16937494
[TBL] [Abstract][Full Text] [Related]
39. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
[TBL] [Abstract][Full Text] [Related]
40. Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients.
Visvanathan K; Lang T; Ryan K; Wilson R; Skinner NA; Thompson AJ; Ahn SH; Weilert F; Abbott W; Gane E; Colledge D; Li K; Locarnini S; Mansell A; Revill PA
J Viral Hepat; 2016 Mar; 23(3):170-9. PubMed ID: 26436722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
